Prognostic impact of serum levels of EGFR and EGFR ligands in early-stage breast cancer

Epidermal growth factor receptor (EGFR) and its ligands are involved in cancer pathogenesis. The emerging role of treatments co-targeting the EGFR system in breast cancer has increased the need to identify companion biomarkers. The aim of this study is to investigate whether pretreatment serum level...

Descripción completa

Detalles Bibliográficos
Autores principales: Kjær, Ina Mathilde, Olsen, Dorte Aalund, Brandslund, Ivan, Bechmann, Troels, Jakobsen, Erik Hugger, Bogh, Søren Bie, Madsen, Jonna Skov
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7538553/
https://www.ncbi.nlm.nih.gov/pubmed/33024132
http://dx.doi.org/10.1038/s41598-020-72944-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7538553/
https://www.ncbi.nlm.nih.gov/pubmed/33024132
http://dx.doi.org/10.1038/s41598-020-72944-1

Ejemplares similares